EARLY DIAGNOSIS OF PANCREATIC CANCER BY DETERMINING GENETIC AND SEROLOGICAL TUMORAL MARKERS
Pancreatic cancer has the worst prognosis among gastrointestinal cancers. The high mortality is justified by the paucity of symptoms and by the lack of response to treatment. The lack of sensitive tumor markers specific to early diagnosis has a major contribution to the poor prognosis.
Main Authors: | Iulia Petre, Mădălina Ilie, Coralia Bleotu, Vasile Șandru, Oana Plotogea, Gabriel Constantinescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Balkan Medical Union
2018-03-01
|
Series: | Archives of the Balkan Medical Union |
Subjects: | |
Online Access: | http://umbalk.org/wp-content/uploads/2018/03/06.EARLY-DIAGNOSIS-OF-PANCREATIC-CANCER.pdf |
Similar Items
-
Chronic periodontitis and its related microRNA
by: ZHANG Zhen, et al.
Published: (2016-06-01) -
Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma
by: Feng SD, et al.
Published: (2017-11-01) -
Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection
by: Bala Shashi, et al.
Published: (2012-07-01) -
miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells
by: Yves-Marie Pers, et al.
Published: (2021-03-01) -
miR-155-5p is Negatively Associated with Acute Pancreatitis and Inversely Regulates Pancreatic Acinar Cell Progression by Targeting Rela and Traf3
by: Sulai Liu, et al.
Published: (2018-11-01)